Related Experiment Video

Updated: May 5, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

6.9K

[Myeloperoxidase in the neurodegenerative process of Parkinson's disease]

P Teismann1

  • 1School of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.

Deutsche Medizinische Wochenschrift (1946)
|November 27, 2013
PubMed

Insights

Myeloperoxidase (MPO) is linked to Parkinson's disease progression. Inhibiting MPO demonstrated a neuroprotective effect in an animal model, suggesting MPO as a therapeutic target.

Area of Science:

  • Biochemistry
  • Immunology
  • Neuroscience

Context:

  • Myeloperoxidase (MPO) is an immune response enzyme.
  • MPO produces hypochlorous acid, causing cellular damage.
  • Parkinson's disease (PD) involves neurodegeneration.

Purpose:

  • To investigate the role of MPO in Parkinson's disease.
  • To determine if MPO or its biomarkers are upregulated in PD.
  • To assess the neuroprotective potential of MPO ablation in a PD model.

Summary:

  • Myeloperoxidase (MPO) and its biomarker 3-Chlorotyrosine are upregulated in the MPTP model of Parkinson's disease and in human PD.
  • Ablation of MPO confers a neuroprotective effect in the MPTP model.
  • MPO's functions contribute to the cellular damage observed in Parkinson's disease.

Impact:

  • Identifies MPO as a key factor in Parkinson's disease pathogenesis.
  • Highlights MPO as a potential therapeutic target for neuroprotection in PD.
  • Provides insights into the molecular mechanisms underlying neurodegeneration in Parkinson's disease.

More Related Videos

Primary Culture of Mouse Dopaminergic Neurons11:58

Primary Culture of Mouse Dopaminergic Neurons

Published on: September 8, 2014

38.4K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.4K

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K